Drug for treating schizophrenia

A technology of schizophrenia and medicine, applied in the field of medicine, can solve problems such as barriers to thinking, inability to distinguish internal and external experiences, etc., and achieve good safety and clear curative effect

Inactive Publication Date: 2013-06-19
徐道慧
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This dissociation phenomenon is believed to create thought-form disorders

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0009] Embodiment Decoction of the present invention

[0010] Weigh 7 grams of Radix Scrophulariae, 13 grams of Dried Ginger, 22 grams of Cornus officinalis, 15 grams of Platycodon grandiflorum, 21 grams of Angelica dahurica, 13 grams of Inula inula, 28 grams of Buliuxing, 11 grams of Tianxian vine, 17 grams of Fangfeng, and 24 grams of Yinchen , Tongcao 27g, Dodder 18g, Bamboo leaves 17g, Imperata 23g, Chrysanthemum 21g, Emlical emblica 16g, Gourilla 16g, Coltsfoot flower 17g, Golden Boil 19g, Swollen knot wind 15g, 14 grams of broken blood flow, 21 grams of senna leaf, 11 grams of blue cloth, 13 grams of leaking reed, 23 grams of Manshanhong, 24 grams of white grass, 14 grams of brocade lantern, 25 grams of mulberry bark, 26 grams of wild horse chasing , 16 grams of Gorgon fruit and 24 grams of yanghua, add 2000 milliliters of water, heat at 80 ℃ for 4 hours in a flask equipped with a condenser tube, and filter. Concentrate the filtrate to 600 milliliters to obtain the deco...

experiment example

[0012] Diagnostic criteria:

[0013] According to the diagnostic criteria of schizophrenia in "Psychiatry": (1) recurrent verbal auditory hallucinations; (2) obvious relaxation of thinking, broken thinking, incoherent speech, or poor thinking content; (3) thought inserted , being withdrawn, disseminated, thinking interrupted, or compulsive thinking; (4) Passive, controlled, or insight experience; (5) Primary delusions (including delusional perception, delusional state of mind) or other absurd delusions (6) Logical inversions of thinking, pathological symbolic thinking, or new words; (7) Emotional inversions, or apparent apathy; (8) Catatonic syndrome, strange behavior, or stupid behavior; (9) Obvious Diminished or lack of will.

[0014] Exclusion criteria:

[0015] Exclude organic mental disorders, and mental disorders caused by psychoactive substances and non-addictive substances. If a patient with schizophrenia who has not been relieved suffers from the above two types of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a drug for treating schizophrenia. The drug is prepared from the following materials in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 pats of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of herba aristolochiae, 10-20 parts of radices sileris, 15-30 parts of oriental wormwood, 20-30 parts of tetrapanax papyriferus, 1-20 parts of cuscuta chinensis, 1-20 parts of lophatherum gracile, 10-25 parts of lalang grass rhizome, 10-30 parts of chrysanthemum, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of flos farfarae, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of radix bupleuri, 10-20 parts of corydalis amabilis, 15-25 parts of cortex mori radicis, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of chinese azalea flower. All the components of the drug for treating schizophrenia in the invention are natural materials, so the drug is good in safety, clear in curative effect and suitable for large-scale promotion clinically.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicament for treating schizophrenia. Background technique [0002] Schizophrenia is a psychiatric disease, a persistent, usually chronic, major mental illness, and the most serious of all mental illnesses, characterized by splits in basic personality, thinking, emotion, and behavior, and differences in mental activity and the environment. Coordination is the most common type of mental illness, and it usually occurs in young and middle-aged adults, which in turn affects behavior and emotion. The main symptom of schizophrenia is considered to be a fragmentation of basic thinking structures and cognition. This dissociation phenomenon is believed to create thought-form disorders and lead to an inability to distinguish between inner and outer experience. People with schizophrenia may report hallucinations themselves, or others may find that their performance is affected by hallucinations...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9068A61P25/18
Inventor 徐道慧
Owner 徐道慧
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products